BG-12, an oral treatment for relapsing-remitting forms of multiple sclerosis, has received FDA approval and will be sold under the name Tecfidera. Manufactured by Biogen Idec, it is the third…
Read More
Multiple Scleresis: Colorado Pediatric Study On April 2, 2013 CBS aired a story about MS in children. During the interview Sr. Teri Schriener was interviewed. Learn more about what…
To learn more about childhood MS, we spoke with Dr. Teri Schreiner, a pediatric neurologist at the Rocky Mountain MS Center at Anschutz Medical Campus. Currently, Dr. Schreiner treats about…
Retinal Thinning and Multiple Sclerosis: What Your Eyes Are Saying BREAKING NEWSExcerp from eMS News, the electronic Newsletter of the Rocky Mountain MS Center Active multiple sclerosis (MS) outside of…
Five Days Until Colorado Gives Day! Colorado Gives Day, December 4, 2012, is an initiative to increase philanthropy in Colorado through online giving. Last year we raised almost $20,000…
In the latest issue of InforMS, we explore what we know about the potential benefits and harms of the existing therapies for multiple sclerosis, how we think today about the…
The N. Daren Writer Society is a membership organization (with no dues or meetings) to recognize people who have named the Rocky Mountain Multiple Sclerosis Center in their will. Members…
In the fight against multiple sclerosis, the Rocky Mountain MS Center is at the forefront of developing improved treatments and a cure. With your support, we will continue our innovative…
When Sarah’s 15-year-old daughter, Ella, lost feeling in her legs, Sarah knew what to do. She called the Rocky Mountain Multiple Sclerosis Center. Sarah, 32, knew what to do for…
[su_row equal_height=”yes”] [su_column size=”2/3″]MS Awareness Month is a chance to bring multiple sclerosis to the forefront, to help advocate for people and families living with MS every day, and to…